RSV Prevention - Breakthroughs and Challenges

N Engl J Med. 2023 Dec 28;389(26):2480-2481. doi: 10.1056/NEJMe2312934.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / therapeutic use
  • Humans
  • Palivizumab / therapeutic use
  • Respiratory Syncytial Virus Infections* / prevention & control

Substances

  • Palivizumab
  • Antiviral Agents